Nomifensine API Manufacturers
compare suppliers & get competitive offers
Filters
Reset
Selected filters:
Type
Production region
Qualifications
To view suppliers for this material, you need to be logged in first.
This is because of international laws regarding narcotic materials. Furthermore, the contents of this page are only accessible if you are professionaly active in the pharmaceutical industry. In case you are, it is possible to register on our platform, and after your account is approved by our team you will be able to view suppliers and send your request.
Looking for Nomifensine API 24526-64-5?
- Description:
- Here you will find a list of producers, manufacturers and traders of Nomifensine. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Nomifensine
- Synonyms:
- Nomifensin , Nomifensina , Nomifensinum
- Cas Number:
- 24526-64-5
- DrugBank number:
- DB04821
- Unique Ingredient Identifier:
- 1LGS5JRP31
About Nomifensine
Here is a short description about Nomifensine. Nomifensine, formerly marketed as Merital capsules, was associated with an increased incidence of hemolytic anemia. The approved application holder removed Merital capsules from the market on January 23, 1986. FDA published a notice of its determination that Merital capsules were removed from the market for safety reasons (see the Federal Register of June 1986 (51 FR 21981)). Approval of the NDA for Merital capsules was withdrawn on March 20, 1992 (see the Federal Register of March 20, 1992 (57 FR 9729)). Also withdrawn from the Canadian and UK markets.
Not sure if this is the exact product you're looking for? Contact the supplier by using the send inquiry button.
